May 31, 2007 - The American Heart Association is launching a community-based program to reduce the toll of the deadliest kind of heart attack: an ST-elevation myocardial infarction (STEMI).

The total blockage of a coronary artery is fatal unless treated quickly — within 30 minutes for clot-dissolving drug treatment, and within 90 minutes for angioplasty.

May 31, 2007 — MediNotes Corporation, a leading provider of best-of-breed electronic medical record solutions for small to medium primary care and specialty medical practices, announced today that they have partnered with Welch Allyn, a leading global manufacturer of frontline medical products and solutions to integrate the Welch Allyn family of connected cardiopulmonary and electronic vital signs devices with MediNotes e version 5.1, the company's point-of-service, wireless data collection and documentation system.

May 30, 2007 — Cardiovascular Associates, Kingsport, TN, has announced the successful implant of a new investigational cardiac medical device called the Optimizer for the treatment of heart failure.

The Optimizer, made by Impulse Dynamics, is an implantable pulse generator that delivers electrical impulses to the heart for patients who suffer from moderate-to-severe heart failure. This procedure was performed at Holston Valley Medical Center, Heart Institute on Wednesday, May 23rd.

May 30, 2007 -- Xtalks and eResearchTechnology will present a Web conference titled, "Best Practices in Cardiac Safety Data Collection Before and After the Thorough QT Trial," on June 7, 10 a.m. to noon, EDT.

May 30, 2007 -- As concern and investigation continue concerning the link between drug-eluting stents and late-stent thrombosis, focus is now turning to the issue of improperly implanted stents by physicians. "The Wall Street Journal" reports this week that cardiologists' overconfidence in the benefits of drug-coated stents may have contributed to sloppy technique.

A recent study sponsored by a stent maker, states the Journal, found that two-thirds of the stents were implanted incorrectly.

May 30, 2007 -- The Canadian Press reports this week that people in the greatest need of cardiac medications and interventions are less likely than moderately ill patients to get the full range of heart drugs and procedures, and it may be because they fail the "eyeball" test.

May 30, 2007 -- Daxor Corp., a medical instrumentation and biotechnology company, announced the June 2007 publication of the Journal of Nuclear Medicine Technology article, "Blood Volume Analysis: A New Technique and New Clinical Interest Reinvigorate a Classic Study."

May 30, 2007 -- The Channel Group, LLC announced today that it has formed Lesanne Life Sciences, LLC, a medical diagnostic company that is developing a simple blood test to detect the occurrence of a stroke.

Lesanne's diagnostic test is able to detect low levels of a patented protein biomarker that is present only in the brain and related central nervous system tissue of healthy individuals.

May 29, 2007 — Stentys says the results of preclinical testing of its bifurcated stent were reported at last week's EuroPCR 2007 Cardiovascular Congress.

Stentys is the first company to develop the next-generation of dedicated drug-eluting stents for treatment of blocked coronary artery bifurcations so that hundreds of thousands of patients might avoid open-chest surgery.

May 29, 2007 — Frost & Sullivan is launching a new end user study on the state of adoption for atrial fibrillation therapies in the U.S. cardiovascular market. Through more than 150 detailed interviews with electrophysiologists, cardiologists and other cardiovascular professionals, the company aims to elucidate key drivers and obstacles to adoption and utilization of various atrial fibrillation treatments.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now